Marshall Wace, LLP Medpace Holdings, Inc. Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 14,434 shares of MEDP stock, worth $4.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,434

Holding current value

$4.94 Million

% of portfolio

0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$308.93 - $363.58 $4.46 Million - $5.25 Million	14,434 New	14,434 $4.8 Million
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $734,964 - $1.07 Million	-2,580 Reduced 3.8%	65,253 $26.4 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $5.44 Million - $7.47 Million	-23,889 Reduced 26.05%	67,833 $20.8 Million
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $14.2 Million - $17.1 Million	-60,599 Reduced 39.78%	91,722 $22.2 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $28.5 Million - $36.6 Million	152,321 New	152,321 $36.6 Million
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $1.12 Million - $1.65 Million	7,300 New	7,300 $1.55 Million
Q1 2020 May 15, 2020	SELL	$61.71 - $101.95 $456,345 - $753,920	-7,395 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $6.83 Million - $8.24 Million	-97,392 Reduced 92.94%	7,395 $621,000
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $5.61 Million - $7.73 Million	-89,950 Reduced 46.19%	104,787 $8.81 Million
Q2 2019 Aug 14, 2019	BUY	$53.64 - $65.42 $10.4 Million - $12.6 Million	193,060 Added 11512.22%	194,737 $12.7 Million
Q1 2019 May 14, 2019	BUY	$49.38 - $70.58 $82,810 - $118,362	1,677 New	1,677 $99,000
Q2 2018 Aug 14, 2018	SELL	$34.03 - $45.46 $435,584 - $581,888	-12,800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $409,984 - $499,839	12,800 New	12,800 $447,000

Others Institutions Holding MEDP

# of Institutions

624

Shares Held

25.1M

Call Options Held

81.2K

Put Options Held

146K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Medpace Holdings, Inc. Transaction History